Investigating Autonomic Nervous System Regulation in Heart Rate Variability, Hypertension, and Cardiac Arrhythmias

Abstract

Background: It was discovered that the ANS is involved in the control of cardiovascular functions one of which is the Heart Rate Variability (HRV). Neurocardiogenic dysfunction means impaired regulation of the ANS, and its disorders are closely connected with hypertension and arrhythmias as vital factors of cardiovascular morbidity. HRV is an index of the ANS which, therefore, research on which is helpful in understanding cardiovascular health. The purpose of this research is to establish links between ANS activation, HRV, hypertension, and arrhythmias, enhancing the comprehensibility of the associated processes.

Objectives: To investigate how impaired ANS function affects the regulation of HRV, high blood pressure, and arrhythmias in an effort to determine early indicators and likely targets for better cardiovascular optimization.

Study Design: A Cross sectional study.

Place and Duration of the Study. Department of Physiology, Saidu College of Dentistry, Saidu Sharif, Swat from March  2023 to March  2024

Methodology: On this cross-sectional research design was used to gather data from 150 patients with cardiovascular complications. The level of activity of the ANS was evaluated using the HRV parameters obtained through ECG. Use of hypertension and arrhythmia status was reported and patients were categorized depending on these ailments. Descriptive statistics utilized in the analysis involves SD and for comparison of selected variables, p-values were computed. Measures RMSSD, and SDNN of HRV as predictors, and correlation tests were used to establish if hypertension/arrhythmia presence influenced the results.

Results: Out of 150 patients, 60 patients had low HRV and 90 high HRV of which low HRV showed strict relation with Hypertension and Arrhythmia (p < 0.05). The mean HRV was statistically significantly lower in hypertensive patients compared to non-hypertensive patients, with the standard deviation of mean of ± 15 ms. The arrhythmia subgroup was characterized by a lower mean ± SD of HRV (42 ± 10 ms) compared to patients without arrhythmia. ANOVA P-values further provided evidence that pre-bed HRV reduction is significant in both hypertension and arrhythmia patients.

Conclusion: Decreased HRV also correlates with hypertension and arrhythmias as previously discussed indicating that ANS is involved in these diseases. Supplementation of cardiovascular techniques through the use of HRV could provide effective means of risk stratification and improved patient outcome following interventions.